2006The Chinese Journal of Clinical PharmacologyRequires access

Pharmacokinetics and relative bioavailability of digoxin solutionin healthy volunteers

Yishi Li

Open publisher page 0 citations

Abstract

Objective To study the pharmacokinetics and relative bioavailability of digoxin solution and tablet in 20 healthy male volunteers.Methods A single oral dose of 0.75 mg digoxin solution(15 mL) or tablet were given to each volunteer according to an open randomized crossover design. The concentration of digoxin in serum was determined by fluorescent polarization immunoassay. The pharmacokinetic parameters were calculated and the bioequivalence were compared.Results The main pharmacokinetic parameters of digoxin solution and tablet were as follows: AUC_ 0→∞ were (65.19±12.09) and (67.59±9.77) μg·h·L -1 ; AUC_ 0→72 were (42.04±6.25) and (44.91±6.03) μg·h·L -1 ; t_ max were (0.64±0.17) and (1.36±0.79) h; C_ max were (3.99± 1.23 ) and (3.53±1.02) μg.·L -1 ; t_ 1/2 were ( 44.66 ±8.12) and ( 44.67 ±5.02)h.The relative bioavailability of the drug was (94.8± 16.4 )%.Conclusion The two digoxin formulations are bioequivalent.

About this research paper

What this paper is about

Objective To study the pharmacokinetics and relative bioavailability of digoxin solution and tablet in 20 healthy male volunteers.Methods A single oral dose of 0.75 mg digoxin solution(15 mL) or tablet were given to each volunteer according to an open randomized crossover design. The concentration of digoxin in serum was determined by fluorescent polarization immunoassay. The pharmacokinetic parameters were calculated and the bioequivalence were compared.Results The main pharmacokinetic parameters of digoxin solution and tablet were as follows: AUC_ 0→∞ were (65.19±12.09) and (67.59±9.77) μg·h·L -1 ; AUC_ 0→72 were (42.04±6.25) and (44.91±6.03) μg·h·L -1 ; t_ max were (0.64±0.17) and (1.36±0.79) h; C_ max were (3.99± 1.23 ) and (3.53±1.02) μg.·L -1 ; t_ 1/2 were ( 44.66 ±8.12) and ( 44.67 ±5.02)h.The relative bioavailability of the drug was (94.8± 16.4 )%.Conclusion The two digoxin formulations are bioequivalent.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To study the pharmacokinetics and relative bioavailability of digoxin solution and tablet in 20 healthy male volunteers.Methods A single oral dose of 0.75 mg digoxin solution(15 mL) or tablet were given to each volunteer according to an open randomized crossover design. The concentration of digoxin in serum was determined by fluorescent polarization immunoassay. The pharmacokinetic parameters were calculated and the bioequivalence were compared.Results The main pharmacokinetic parameters of digoxin solution and tablet were as follows: AUC_ 0→∞ were (65.19±12.09) and (67.59±9.77) μg·h·L -1 ; AUC_ 0→72 were (42.04±6.25) and (44.91±6.03) μg·h·L -1 ; t_ max were (0.64±0.17) and (1.36±0.79) h; C_ max were (3.99± 1.23 ) and (3.53±1.02) μg.·L -1 ; t_ 1/2 were ( 44.66 ±8.12) and ( 44.67 ±5.02)h.The relative bioavailability of the drug was (94.8± 16.4 )%.Conclusion The two digoxin formulations are bioequivalent.

Key concepts: Bioequivalence, Digoxin, Bioavailability, Pharmacokinetics, Volunteer, Crossover study, Pharmacology, Fluorescence polarization immunoassay

Related papers

Back to paper searchBrowse research topicsOriginal source
Pharmacokinetics and relative bioavailability of digoxin solutionin healthy volunteers — Research Paper | ScholarLens